※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
응급 수술 서비스 시장의 성장과 동향 :
Grand View Research, Inc.의 최신 보고서에 따르면 세계 응급 수술 서비스 시장 규모는 2030년까지 320억 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 연평균 5.74% 성장할 것으로 예상됩니다. 성장하고 있습니다.
이 시장은 즉각적인 개입이 필요한 급성 및 응급 상황에 대해 제공되는 다양한 수술 절차 및 서비스를 포괄합니다.
보험 가입자 증가는 시장에 큰 영향을 미칩니다. 건강 보험 가입자 증가는 긴급한 증상에 대한 신속한 치료를 요구할 가능성이 높으며, 2040년까지 65세 이상 미국인의 수는 8,000만 명을 넘어설 것으로 예상되며, 일상적인 도움이 필요한 85세 이상 노인은 2000년에 비해 4배로 증가할 것으로 예상됩니다. 이러한 추세는 응급 수술에 대한 수요를 증가시키고 의료 서비스 제공업체가 서비스를 개선하도록 유도할 것입니다.
당뇨병, 심장병, 암과 같은 만성 질환의 유병률 증가는 시장 성장을 크게 촉진하고 있습니다. 세계보건기구(WHO)에 따르면 전 세계적으로 약 4억 2,200만 명이 당뇨병을 앓고 있으며, 대부분 중저소득 국가에 거주하고 있습니다. 매년 당뇨병은 약 150만 명의 사망 원인이 되고 있습니다.
응급 수술 서비스 시장 보고서 - 하이라이트
- 수술법별로는 복부 수술이 2023년 29.7%의 가장 큰 매출 점유율을 차지하며 시장을 주도했습니다. 최소침습적 수술을 포함한 수술 기법의 발전과 비만 관련 합병증 유병률 증가 등의 요인도 이러한 성장에 기여하고 있습니다.
- 최종 용도별로는 병원 부문이 종합적인 인프라, 전문 수술팀의 가용성, 첨단 의료 기술 덕분에 2023년 64.8%의 가장 큰 매출 점유율을 차지하며 시장을 장악했습니다.
- 2024년 3월, 노던헬스(Northern Health)는 테라스에서 제공하는 수술 서비스에 정형외과 서비스를 도입하여 이 지역에서 이용할 수 있는 의료 서비스의 범위를 확대했습니다.
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 응급 수술 서비스 시장 변수, 동향, 범위
- 시장 계통 전망
- 시장 역학
- 시장 성장 촉진요인 분석
- 시장 성장 억제요인 분석
- 응급 수술 서비스 시장 분석 툴
- 업계 분석 - Porter의 Five Forces 분석
- PESTEL 분석
제4장 응급 수술 서비스 시장 : 시술 추정·동향 분석
- 세계의 응급 수술 서비스 시장 : 시술별 대시보드
- 세계의 응급 수술 서비스 시장 : 시술별 도변동 분석
- 최종 용도별, 매출
- 복부 수술
- 외상 수술
- 혈관 외과
- 흉부 외과
- 긴급 정형외과 수술
- 기타
제5장 응급 수술 서비스 시장 : 최종 용도 추정·동향 분석
- 세계의 응급 수술 서비스 시장 : 최종 용도별 대시보드
- 세계의 응급 수술 서비스 시장 : 최종 용도별 도변동 분석
- 최종 용도별, 매출
- 병원
- 전문 클리닉
- 외래수술센터(ASC)
- 기타
제6장 응급 수술 서비스 시장 : 시술별과 최종 용도별 지역 추정·동향 분석
- 지역 대시보드
- 시장 규모, 예측 동향 분석, 2018년-2030년 :
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
제7장 경쟁 구도
- 기업/경쟁 분류
- 벤더 구도
- 주요 유통업체 및 채널 파트너 리스트
- Key company market share analysis, 2023
- HCA Management Services, LP
- TH Medical.
- Ascension
- Cleveland Clinic
- Mayo Clinic
- Banner Health
- Health Security Partners(HSP)
- Providence
- Universal Health Services
- MedStar Health
LSH 24.10.30
Emergency General Surgery Services Market Growth & Trends:
The global emergency general surgery services market size is anticipated to reach USD 32.0 billion by 2030 and is projected to grow at a CAGR of 5.74% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market encompasses a range of surgical procedures and services provided for acute and urgent conditions requiring immediate intervention.
The increasing number of insured individuals significantly influences the market. More people with health insurance are likely to seek prompt medical attention for urgent conditions. By 2040, the number of Americans aged 65 and older is expected to exceed 80 million, while those aged 85 and above needing daily assistance are expected to quadruple from 2000 levels. This trend boosts demand for emergency surgeries and prompts healthcare providers to improve their services.
The increasing incidence of chronic diseases such as diabetes, heart disease, and cancer significantly drives the market growth. The chronic conditions lead to acute complications requiring urgent surgical care. According to WHO, approximately 422 million individuals globally are affected by diabetes, with a significant number residing in low- and middle-income nations. Each year, diabetes is responsible for around 1.5 million deaths.
Emergency General Surgery Services Market Report Highlights:
- Based on procedure type, abdominal surgery dominated the market with the largest revenue share of 29.7% in 2023. Factors such as advancements in surgical techniques, including minimally invasive procedures, and the rising prevalence of obesity-related complications also contribute to this growth.
- Based on end use, the hospitals segment dominated the market with the largest revenue share of 64.8% in 2023 due to their comprehensive infrastructure, availability of specialized surgical teams, and advanced medical technology.
- In March 2024, Northern Health introduced orthopedic services to its surgical offerings in Terrace, enhancing the range of medical care available in the region.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Procedure
- 1.2.2. End Use
- 1.2.3. Regional scope
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Procedure Outlook
- 2.2.2. End Use Outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Emergency General Surgery Services Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising prevalence of chronic diseases
- 3.2.1.2. Technological advancements
- 3.2.1.3. Aging population
- 3.2.1.4. Increasing demand for enhanced emergency care infrastructure
- 3.2.2. Market restraint analysis
- 3.2.2.1. Lack of adequate facilities
- 3.3. Emergency General Surgery Services Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Emergency General Surgery Services Market: Procedure Estimates & Trend Analysis
- 4.1. Global Emergency General Surgery Services Market: Procedure Dashboard
- 4.2. Global Emergency General Surgery Services Market: Procedure Movement Analysis
- 4.3. Global Emergency General Surgery Services Market by Procedure, Revenue
- 4.4. Abdominal Surgery
- 4.4.1. Abdominal surgery market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Trauma Surgery
- 4.5.1. Trauma surgery market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Vascular Surgery
- 4.6.1. Vascular surgery market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7. Thoracic Surgery
- 4.7.1. Thoracic surgery market estimates and forecasts 2018 to 2030 (USD Million)
- 4.8. Emergency Orthopedic Surgery
- 4.8.1. Emergency orthopedic surgery market estimates and forecasts 2018 to 2030 (USD Million)
- 4.9. Other
- 4.9.1. Other market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Emergency General Surgery Services Market: End Use Estimates & Trend Analysis
- 5.1. Global Emergency General Surgery Services Market: End Use Dashboard
- 5.2. Global Emergency General Surgery Services Market: End Use Movement Analysis
- 5.3. Global Emergency General Surgery Services Market Estimates and Forecasts, By End Use, Revenue (USD Million)
- 5.4. Hospitals
- 5.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Specialty Clinics
- 5.5.1. Specialty clinics market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Ambulatory Surgery Centers (ASCs)
- 5.6.1. Ambulatory Surgery Centers (ASCs) market estimates and forecasts 2018 to 2030 (USD Million)
- 5.7. Others
- 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Emergency General Surgery Services Market: Regional Estimates & Trend Analysis by Procedure and End Use
- 6.1. Regional Dashboard
- 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 6.3. North America
- 6.3.1. U.S.
- 6.3.1.1. Key country dynamics
- 6.3.1.2. Regulatory framework/ reimbursement structure
- 6.3.1.3. Competitive scenario
- 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.2. Canada
- 6.3.2.1. Key country dynamics
- 6.3.2.2. Regulatory framework/ reimbursement structure
- 6.3.2.3. Competitive scenario
- 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.3. Mexico
- 6.3.3.1. Key country dynamics
- 6.3.3.2. Regulatory framework/ reimbursement structure
- 6.3.3.3. Competitive scenario
- 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4. Europe
- 6.4.1. UK
- 6.4.1.1. Key country dynamics
- 6.4.1.2. Regulatory framework/ reimbursement structure
- 6.4.1.3. Competitive scenario
- 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.2. Germany
- 6.4.2.1. Key country dynamics
- 6.4.2.2. Regulatory framework/ reimbursement structure
- 6.4.2.3. Competitive scenario
- 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. France
- 6.4.3.1. Key country dynamics
- 6.4.3.2. Regulatory framework/ reimbursement structure
- 6.4.3.3. Competitive scenario
- 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.4. Italy
- 6.4.4.1. Key country dynamics
- 6.4.4.2. Regulatory framework/ reimbursement structure
- 6.4.4.3. Competitive scenario
- 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.5. Spain
- 6.4.5.1. Key country dynamics
- 6.4.5.2. Regulatory framework/ reimbursement structure
- 6.4.5.3. Competitive scenario
- 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.6. Norway
- 6.4.6.1. Key country dynamics
- 6.4.6.2. Regulatory framework/ reimbursement structure
- 6.4.6.3. Competitive scenario
- 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.7. Sweden
- 6.4.7.1. Key country dynamics
- 6.4.7.2. Regulatory framework/ reimbursement structure
- 6.4.7.3. Competitive scenario
- 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.8. Denmark
- 6.4.8.1. Key country dynamics
- 6.4.8.2. Regulatory framework/ reimbursement structure
- 6.4.8.3. Competitive scenario
- 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Asia Pacific
- 6.5.1. Japan
- 6.5.1.1. Key country dynamics
- 6.5.1.2. Regulatory framework/ reimbursement structure
- 6.5.1.3. Competitive scenario
- 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.2. China
- 6.5.2.1. Key country dynamics
- 6.5.2.2. Regulatory framework/ reimbursement structure
- 6.5.2.3. Competitive scenario
- 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.3. India
- 6.5.3.1. Key country dynamics
- 6.5.3.2. Regulatory framework/ reimbursement structure
- 6.5.3.3. Competitive scenario
- 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.4. Australia
- 6.5.4.1. Key country dynamics
- 6.5.4.2. Regulatory framework/ reimbursement structure
- 6.5.4.3. Competitive scenario
- 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.5. South Korea
- 6.5.5.1. Key country dynamics
- 6.5.5.2. Regulatory framework/ reimbursement structure
- 6.5.5.3. Competitive scenario
- 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.6. Thailand
- 6.5.6.1. Key country dynamics
- 6.5.6.2. Regulatory framework/ reimbursement structure
- 6.5.6.3. Competitive scenario
- 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Latin America
- 6.6.1. Brazil
- 6.6.1.1. Key country dynamics
- 6.6.1.2. Regulatory framework/ reimbursement structure
- 6.6.1.3. Competitive scenario
- 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.2. Argentina
- 6.6.2.1. Key country dynamics
- 6.6.2.2. Regulatory framework/ reimbursement structure
- 6.6.2.3. Competitive scenario
- 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7. MEA
- 6.7.1. South Africa
- 6.7.1.1. Key country dynamics
- 6.7.1.2. Regulatory framework/ reimbursement structure
- 6.7.1.3. Competitive scenario
- 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.2. Saudi Arabia
- 6.7.2.1. Key country dynamics
- 6.7.2.2. Regulatory framework/ reimbursement structure
- 6.7.2.3. Competitive scenario
- 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.3. UAE
- 6.7.3.1. Key country dynamics
- 6.7.3.2. Regulatory framework/ reimbursement structure
- 6.7.3.3. Competitive scenario
- 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.4. Kuwait
- 6.7.4.1. Key country dynamics
- 6.7.4.2. Regulatory framework/ reimbursement structure
- 6.7.4.3. Competitive scenario
- 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Company/Competition Categorization
- 7.2. Vendor Landscape
- 7.2.1. List of key distributors and channel partners
- 7.2.2. Key company market share analysis, 2023
- 7.2.3. HCA Management Services, L.P.
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. TH Medical.
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. Ascension
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Cleveland Clinic
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. Mayo Clinic
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. Banner Health
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. Health Security Partners (HSP)
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives
- 7.2.10. Providence
- 7.2.10.1. Company overview
- 7.2.10.2. Financial performance
- 7.2.10.3. Product benchmarking
- 7.2.10.4. Strategic initiatives
- 7.2.11. Universal Health Services
- 7.2.11.1. Company overview
- 7.2.11.2. Financial performance
- 7.2.11.3. Product benchmarking
- 7.2.11.4. Strategic initiatives
- 7.2.12. MedStar Health
- 7.2.12.1. Company overview
- 7.2.12.2. Financial performance
- 7.2.12.3. Product benchmarking
- 7.2.12.4. Strategic initiatives